These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24710030)

  • 1. Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E-/- mice and rabbits fed a high-fat and -cholesterol diet.
    Chatterjee S; Bedja D; Mishra S; Amuzie C; Avolio A; Kass DA; Berkowitz D; Renehan M
    Circulation; 2014 Jun; 129(23):2403-13. PubMed ID: 24710030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-/- mice.
    Mishra S; Bedja D; Amuzie C; Avolio A; Chatterjee S
    Biochem Biophys Res Commun; 2015 Sep; 465(1):159-64. PubMed ID: 26253472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1/apolipoprotein A-I pathway: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux accelerator.
    Glaros EN; Kim WS; Quinn CM; Wong J; Gelissen I; Jessup W; Garner B
    J Biol Chem; 2005 Jul; 280(26):24515-23. PubMed ID: 15890646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved intervention of atherosclerosis and cardiac hypertrophy through biodegradable polymer-encapsulated delivery of glycosphingolipid inhibitor.
    Mishra S; Bedja D; Amuzie C; Foss CA; Pomper MG; Bhattacharya R; Yarema KJ; Chatterjee S
    Biomaterials; 2015 Sep; 64():125-135. PubMed ID: 26111596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
    Bietrix F; Lombardo E; van Roomen CP; Ottenhoff R; Vos M; Rensen PC; Verhoeven AJ; Aerts JM; Groen AK
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):931-7. PubMed ID: 20167657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myriocin and d-PDMP ameliorate atherosclerosis in ApoE-/- mice via reducing lipid uptake and vascular inflammation.
    Yu Z; Peng Q; Li S; Hao H; Deng J; Meng L; Shen Z; Yu W; Nan D; Bai Y; Huang Y
    Clin Sci (Lond); 2020 Mar; 134(5):439-458. PubMed ID: 32091078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glycosphingolipid synthesis reverses skin inflammation and hair loss in ApoE-/- mice fed western diet.
    Bedja D; Yan W; Lad V; Iocco D; Sivakumar N; Bandaru VVR; Chatterjee S
    Sci Rep; 2018 Jul; 8(1):11463. PubMed ID: 30061606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glycosphingolipid synthesis by threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and the modulation of IL-1beta-stimulated expression of inducible nitric oxide synthase in rat aortic smooth muscle cells.
    Weber AA; Seul C; Harth V; Ko Y; Seewald S; Vetter H; Sachinidis A
    Br J Pharmacol; 1998 Mar; 123(5):906-10. PubMed ID: 9535019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of metabolic syndrome and reduction in body weight in type II diabetic mice by inhibiting glycosphingolipid synthesis.
    Chatterjee S; Zheng L; Ma S; Bedja D; Bandaru VVR; Kim G; Rangecroft AB; Iocco D; Campbell SA
    Biochem Biophys Res Commun; 2020 Apr; 525(2):455-461. PubMed ID: 32107002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a glycolipid inhibitor to ameliorate renal cancer in a mouse model.
    Chatterjee S; Alsaeedi N; Hou J; Bandaru VV; Wu L; Halushka MK; Pili R; Ndikuyeze G; Haughey NJ
    PLoS One; 2013; 8(5):e63726. PubMed ID: 23671696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current topics in pharmacological research on bone metabolism: osteoclast differentiation regulated by glycosphingolipids.
    Fukumoto S; Iwamoto T; Sakai E; Yuasa K; Fukumoto E; Yamada A; Hasegawa T; Nonaka K; Kato Y
    J Pharmacol Sci; 2006 Mar; 100(3):195-200. PubMed ID: 16538029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsonists and firefighters: the perpetual inflammatory civil war for survival.
    Karliner JS
    Circulation; 2014 Jun; 129(23):2368-70. PubMed ID: 24710031
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.
    Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X
    Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipids in atherosclerosis and vascular biology.
    Chatterjee S
    Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1523-33. PubMed ID: 9763522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation.
    Chatterjee S; Ghosh N
    Glycobiology; 1996 Apr; 6(3):303-11. PubMed ID: 8724138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.
    Matsuo M; Ito F; Konto A; Aketa M; Tomoi M; Shimomura K
    Biochim Biophys Acta; 1995 Dec; 1259(3):254-60. PubMed ID: 8541332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of ganglioside biosynthesis and neurite outgrowth of primary cultured neurons by L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol.
    Usuki S; Hamanoue M; Kohsaka S; Inokuchi J
    J Neurochem; 1996 Nov; 67(5):1821-30. PubMed ID: 8863486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Modulation of Glycosphingolipid Metabolism.
    Inokuchi JI; Ode T; Hara-Yokoyama M
    Methods Mol Biol; 2018; 1804():401-410. PubMed ID: 29926420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of glycosphingolipid biosynthesis by L-threo-1-phenyl-2-decanoylamino-1-propanol and its homologs in B16 melanoma cells.
    Inokuchi J; Usuki S; Jimbo M
    J Biochem; 1995 Apr; 117(4):766-73. PubMed ID: 7592537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.